Pneumotyl

Pneumotyl Adverse Reactions

acetylcysteine

Manufacturer:

Hermes

Distributor:

Natrapharm
Full Prescribing Info
Adverse Reactions
The evaluation of adverse reactions is based on the following information on frequencies: Very common: (≥1/10); Common: (≥1/100 up to <1/10); Uncommon: ( ≥1/1,000 up to <1/100); Rare: (≥1/10,000 up to <1/1,000); Very rare: (<1/10,000); Not known: (cannot be estimated from the available data).
Immune system disorders:Uncommon: Hypersensitivity reactions; Very rare: Anaphylactic shock, anaphylactic/anaphylactoid reactions.
Nervous system disorders: Uncommon: Headache.
Ear and labyrinth disorders: Uncommon: Tinnitus.
Cardiac disorders: Uncommon: Tachycardia.
Vascular disorders: Uncommon: Hypotension; Very rare: Hemorrhage.
Respiratory, thoracic and mediastinal disorders: Rare: Dyspnoea, bronchospasm.
Gastrointestinal disorders: Uncommon: Nausea, vomiting, diarrhoea, abdominal pain; Rare: Dyspepsia.
Skin and subcutaneous tissue disorders: Uncommon: Urticaria, rash, angioedema, itching, exanthema.
General disorders and administration site conditions: Uncommon: Fever; Not known: Facial edema.
A decreased blood platelet aggregation in the presence of acetylcysteine has been confirmed by different studies. The clinical relevance has not yet been clarified to date.